TheInvestigatorholds theprimary responsibilityfor ensuring the accuracy, completeness, and timeliness of Case Report Form (CRF) entries. This responsibility is mandated by regulatory requirements underICH E6(R2) Good Clinical Practice (GCP).
The investigator may delegate CRF completion to aqualified designee (e.g., site coordinator), but the ultimate accountability remains with the investigator. The investigator’s signature (electronic or manual) on the CRF serves as certification that the data accurately reflect the source documents and the patient’s participation.
TheGCDMP (Chapter: CRF Design and Data Collection)reinforces this by stating that while data managers ensure design quality and CRAs verify consistency with source data,the investigator is legally responsible for CRF accuracy.
Thus,option D (Investigator)is correct, as it aligns with both GCP and CCDM standards.
Reference (CCDM-Verified Sources):
ICH E6(R2) GCP, Section 4.9 – Records and Reports (Investigator Responsibilities)
SCDM GCDMP, Chapter: CRF Design and Data Collection, Section 5.1 – Investigator’s Role in Data Accuracy
FDA 21 CFR Part 312.62 – Investigator Recordkeeping and Record Retention